Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.
暂无分享,去创建一个
N. Lundbom | M. Orho-Melander | C. Forsblom | P. Groop | A. Hakkarainen | H. Yki-Järvinen | K. Sevastianova | G. Llauradó | Sanja Sädevirta | Ksenia Sevastianova
[1] H. Yki-Järvinen. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. , 2014, The lancet. Diabetes & endocrinology.
[2] J. Romijn,et al. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long‐term continuous subcutaneous insulin infusion therapy , 2013, Diabetes/metabolism research and reviews.
[3] M. Rewers,et al. The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. , 2013, The Journal of clinical endocrinology and metabolism.
[4] S. Klein,et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. , 2012, Gastroenterology.
[5] J. Olefsky,et al. The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.
[6] N. Lundbom,et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. , 2011, The American journal of clinical nutrition.
[7] M. Stepanova,et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] M. Wolzt,et al. Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes , 2011, Journal of internal medicine.
[9] E. Bonora,et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. , 2010, Journal of hepatology.
[10] N. Lundbom,et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.
[11] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.
[12] A. Kotronen,et al. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. , 2008, Gastroenterology.
[13] A. Kotronen,et al. Effect of liver fat on insulin clearance. , 2007, American journal of physiology. Endocrinology and metabolism.
[14] K. Pietiläinen,et al. Liver fat in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[15] A. Häkkinen,et al. Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. , 2007, American journal of physiology. Endocrinology and metabolism.
[16] H. Yki-Järvinen,et al. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study , 2006, Diabetologia.
[17] P. Scifo,et al. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes , 2005, Diabetologia.
[18] Merlin C. Thomas,et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.
[19] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[20] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.
[21] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.
[22] H. Beck-Nielsen,et al. Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with Type 1 (insulin-dependent) diabetes , 1987, Diabetologia.
[23] A. Häkkinen,et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.
[24] R. Hammer,et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. , 2000, Molecular cell.
[25] A. Häkkinen,et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. , 2000, Diabetes.
[26] H. Yki-Järvinen,et al. Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues , 1997, Diabetologia.
[27] L. Groop,et al. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance , 1997, Diabetologia.
[28] P. Groop,et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. , 1996, Circulation.
[29] H. Yki-Järvinen,et al. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. , 1995, The Journal of clinical endocrinology and metabolism.
[30] S. Coppack,et al. Lack of effect of hyperglycemia on lipolysis in humans. , 1990, The American journal of physiology.
[31] M. Jensen,et al. Effects of glucagon on free fatty acid metabolism in humans. , 1991, The Journal of clinical endocrinology and metabolism.
[32] T. Jenssen,et al. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. , 1990, Diabetes.
[33] M. Jensen,et al. Lack of effect of hyperglycemia on lipolysis in humans. , 1990, The American journal of physiology.
[34] L. Groop,et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.
[35] H. Yki-Järvinen,et al. Kinetics of glucose disposal in whole body and across the forearm in man. , 1987, The Journal of clinical investigation.
[36] H. Yki-Järvinen,et al. Natural course of insulin resistance in type I diabetes. , 1986, The New England journal of medicine.
[37] H. Beck-Nielsen,et al. Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activities. , 1985, The Journal of clinical investigation.
[38] H. Yki-Järvinen,et al. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. , 1984, The Journal of clinical endocrinology and metabolism.
[39] R. Rizza,et al. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. , 1984, The Journal of clinical investigation.
[40] H. Yki-Järvinen,et al. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. , 1984, The Journal of clinical endocrinology and metabolism.
[41] R. DeFronzo,et al. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. , 1983, The American journal of physiology.
[42] P. Cryer,et al. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. , 1982, The Journal of clinical investigation.
[43] Gerich Je. Physiology of glucagon. , 1981 .
[44] J. Gerich,et al. Physiology of glucagon. , 1981, International review of physiology.
[45] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[46] G. Hetényi,et al. Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. , 1971, Metabolism: clinical and experimental.
[47] R. Steele,et al. INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.